Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
23.02.2023 11:25:09

EQS-AFR: STADA Arzneimittel AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: STADA Arzneimittel AG / Preliminary announcement on the disclosure of financial statements
STADA Arzneimittel AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

23.02.2023 / 11:25 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


STADA Arzneimittel AG hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report of the group

Language: German
Date of disclosure: March 06, 2023
Address: https://www.stada.com/de/gj2022-geschaeftsbericht.pdf

Language: English
Date of disclosure: March 06, 2023
Address: https://www.stada.com/fy2022-annual-report.pdf


23.02.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
Internet: www.stada.de

 
End of News EQS News Service

1567109  23.02.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1567109&application_name=news&site_id=smarthouse

Analysen zu STADAmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!